Let's be frank. The last really big push upward was when the former CEO died and folks thought that could be the stimulus for a buy out. None of us expected this Chinese water drip torture of a trial that moves with the speed of a lathargic turtle.
If Rabin isn't concerned about this, I'd be very surprised. In fact, ACTC is not going to have a continuous well of cash ahead. The Street chews up early stage biotechs for sport and spits out the well-meaning stockholders bloodied and bruised.
As the stock is in the 6 cent range now, down tics are going to hurt more and more.
Which brings up a friends' experience with penny stocks. He bought a company for 3 cents a share. He was convinced that the net current assets were worth more than 3 cents a share. That stock fell to 3 100's of a cent, a 90% loss of value. Yes, the shares traded once in a while. But, that company couldn't sell itself and had to dilute the shares a couple of times.
I say this because you have to be wary of a pig-headed CEO that won't wake up and smell the coffee because his ego is in the way.